跳至主要内容
临床试验/NCT05628584
NCT05628584已完成不适用

The Impact of High or Low FODMAP Diets on Postprandial Glucose Response and Gut Microbiota in Individuals with Prediabetes Treated with Metformin: a Randomized Crossover Controlled-Feeding Trial

Elaine Chow1 个研究点 分布在 1 个国家目标入组 26 人开始时间: 2022年11月11日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Elaine Chow
入组人数
26
试验地点
1
主要终点
Differences in postprandial glycemia

研究概览

简要总结

This is a prospective, double blinded, randomised cross over feeding trial examine high or low FODMAP diet in combination with metformin on postprandial glucose responses and gastrointestinal tolerability and gut microbiota profiles.

The trial will compare high or low FODMAP diet, each of 10 days duration in combination with 5 days metformin, separated by a washout period of at least 2 weeks.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-70 years
  • Body mass index 18 to 40 kg/m 2
  • Prediabetes defined as impaired fasting PG 5.6-6.9 mmol/l and/or impaired glucose tolerance with 2-hour PG 7.8-11.1 mmol/l on 75g oral glucose tolerance test (OGTT) and/or HbA1c 5.7-6.4% at screening

排除标准

  • Currently pregnant, lactating, as demonstrated by a positive pregnancy test at screening or planning pregnancy
  • Known current diabetes
  • Current or previous use of glucose-lowering or weight loss drugs in 3 months prior to screening
  • Concurrent participation in other weight loss or lifestyle intervention programmes
  • Current use or recent exposure to any medication that in the opinion of the investigator could have an influence on the patient's ability to participate in this study or on the performance of the test device.
  • Recent intake of prebiotic/probiotic or antibiotic, immunosuppressants (within 8 weeks of randomisation)
  • Extensive skin changes/diseases that preclude wearing the FGM on normal skin at the proposed application sites (e.g., extensive psoriasis, recent burns or severe sunburn, extensive eczema, extensive scarring, extensive tattoos, dermatitis herpetiformis).
  • Known uncontrolled thyrotoxicosis
  • Known vitamin B deficiency
  • Known irritable bowel syndrome or gastrointestinal disorders
  • Estimated glomerular filtration rate (eGFR) <45 ml/min/1.73m2 at screening
  • Current use of steroids
  • Have a known allergy to medical-grade adhesives
  • Known current or recent alcohol or drug abuse
  • Hypersensitivity to metformin
  • Acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma within 3 months of randomisation
  • Currently participating in another investigational study protocol where the testing or results may interfere with study compliance, diagnostic results, or data collection.
  • An identified protected vulnerable patient (including but not limited to those in detention, or a prisoner).
  • Participants who are on a vegetarian or vegan diet as their habitual diet at screening.
  • Participants with clinically significant food allergy to components of the study diet

结局指标

主要结局

Differences in postprandial glycemia

时间窗: 10 days

incremental area under curve on continuous glucose monitoring post meal

次要结局

  • Body weight(10 days)
  • Glucose response to 75g oral glucose tolerance test(10 days)
  • Insulin response to 75g oral glucose tolerance test(10 days)
  • Change in alpha diversity of gut microbiota(10 days)
  • Change in beta diversity of gut microbiota(10 days)
  • Gastrointestinal symptoms(10 days)

研究者

发起方
Elaine Chow
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Elaine Chow

Clinical Assistant Professor

Chinese University of Hong Kong

研究点 (1)

Loading locations...

相似试验